Sponsor

Otsuka America Pharmaceutical

Clinical research sponsor

Published trials37
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

37 shown
A Study of Multiple Doses of Vesnarinone in Advanced HIV DiseaseNCT00002337 · lead sponsor
COMPLETED
A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's SarcomaNCT00002131 · lead sponsor
COMPLETED
A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected PersonsNCT00002130 · lead sponsor
COMPLETED
A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3NCT00002129 · lead sponsor
COMPLETED
Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium AdministrationNCT05190744 · collaborator · 2022-09-01
COMPLETED
Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying RespondersNCT02476409 · collaborator · 2015-07-01
COMPLETED
Aripiprazole, Abilify Maintena Collaborative Clinical ProtocolNCT02472652 · collaborator · 2015-06-01
TERMINATED
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase SchizophrenicsNCT02360319 · collaborator · 2014-12-11
COMPLETED
Aquaresis Utility for Hyponatremic Acute Heart Failure StudyNCT02183792 · collaborator · 2014-12-01
COMPLETED
Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With SchizophreniaNCT02282085 · collaborator · 2014-12-01
UNKNOWN
Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and MetabolismNCT02237417 · collaborator · 2014-09-01
COMPLETED
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With SchizophreniaNCT01683058 · collaborator · 2013-01-01
COMPLETED
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With SchizophreniaNCT01663532 · collaborator · 2012-10-01
COMPLETED
Pilot Study of Using Copeptin to Predict Response to TolvaptanNCT01346072 · collaborator · 2011-04-01
COMPLETED
A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic SyndromeNCT00508157 · collaborator · 2007-11-01
TERMINATED
A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeNCT00338273 · collaborator · 2006-12-01
WITHDRAWN
Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.NCT00325689 · collaborator · 2006-07-01
COMPLETED
A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic PatientsNCT00300846 · collaborator · 2005-12-01
COMPLETED
A Switch Study of BMS-337039 in Schizophrenic Out-patientsNCT00232687 · collaborator · 2005-06-01
COMPLETED
A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric PracticesNCT00292409 · collaborator · 2005-03-01
COMPLETED
A Study of Aripiprazole in Patients With Major Depressive DisorderNCT00105196 · collaborator · 2005-03-01
COMPLETED
Effect on Cognitive Function of a Treatment With AripiprazoleNCT00329810 · collaborator · 2005-03-01
COMPLETED
A Study of Adjunctive Aripiprazole in Participants With Major Depressive DisorderNCT00095758 · collaborator · 2004-09-01
COMPLETED
A Long-Term Study of Aripiprazole in Patients With Major Depressive DisorderNCT00095745 · collaborator · 2004-09-01
COMPLETED
Schizophrenia Trial of AripiprazoleNCT00237913 · collaborator · 2004-07-01
COMPLETED
A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeNCT00094432 · collaborator · 2004-06-01
COMPLETED
A Study of Adjunctive Aripiprazole in Patients With Major Depressive DisorderNCT00095823 · collaborator · 2004-06-01
COMPLETED
Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective DisorderNCT00095524 · collaborator · 2004-03-01
COMPLETED
Aripiprazole Oral Acceptability TrialNCT00101569 · collaborator · 2004-03-01
COMPLETED
Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression EpisodeNCT00080314 · collaborator · 2004-01-01
COMPLETED
Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With DementiaNCT00095719 · collaborator · 2003-12-01
COMPLETED
Study of Three Doses of Aripiprazole in Patients With Acute SchizophreniaNCT00080327 · collaborator · 2003-11-01
COMPLETED
Aripiprazole in Patients With Psychosis Associated With Parkinson's DiseaseNCT00095810 · collaborator · 2003-07-01
COMPLETED
Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical TrialsNCT00239356 · collaborator · 2003-03-01
COMPLETED
A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric PracticesNCT00237939 · collaborator · 2002-09-01
COMPLETED
Broad Effectiveness: Study With AripiprazoleNCT00036361 · collaborator · 2002-07-01
COMPLETED
Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's TypeNCT01438060 · collaborator · 2000-08-01
COMPLETED

Sponsor roles

collaborator33
lead sponsor4

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.